Probiodrug AG 07.11.2014 19:50 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Probiodrug AG Halle (Saale), Germany Handelsregister: Amtsgericht Stendal, HRB 213719 (Commercial Register: Local Court of Stendal, HRB 213719) ISIN: DE0007921835 Publication of notifications of voting rights pursuant to sec. 21 para. 1a WpHG (Wertpapierhandelsgesetz - German Securities Trading Act) 1. Coöperatief LSP IV U.A., Johannes Vermeerplein 9, 1071 DV Amsterdam, Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to 442.806 voting rights). 2. LSP IV Management B.V., Johannes Vermeerplein 9, 1071 DV Amsterdam, Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 3, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to 442.806 voting rights). 8.45% of the voting rights (corresponding to 442.806 voting rights) are to be attributed to LSP IV Management B.V. pursuant to sec. 22 para. 2 sentence 1 no. 6 WpHG. The voting rights that are to be attributed to LSP IV Management B.V. are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: Coöperatief LSP IV U.A. 3. LSP Management Group B.V., Johannes Vermeerplein 9, 1071 DV Amsterdam, Netherlands, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 4, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 8.45% on October 27, 2014 (corresponding to 442.806 voting rights). 8.45% of the voting rights (corresponding to 442.806 voting rights) are to be attributed to LSP Management Group B.V. pursuant to sec. 22 para. 2 sentence 1 no. 6 and sentence 2 WpHG. The voting rights that are to be attributed to LSP Management Group B.V. are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: Coöperatief LSP IV U.A. 4. Biotech Growth N.V., Snipweg 26, Willemstad, Curacao, the Netherlands Antilles (Dutch Caribbean), informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 15.06% on October 27, 2014 (corresponding to 789,439 voting rights). 5. BB Biotech AG, Vordergasse 3, 8200 Schaffhausen, Switzerland, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 3, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 15.06% on October 27, 2014 (corresponding to 789,439 voting rights). 15.06% of the voting rights (corresponding to 789,439 voting rights) are to be attributed to BB Biotech AG pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to BB Biotech AG are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: Biotech Growth N.V. 6. HBM Healthcare Investments (Cayman) Ltd., Governor's Square, Suite #4-212-2, 23 Lime Tree Bay Avenue, George Town, Grand Cayman, Cayman Islands, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 9.44% on October 27, 2014 (corresponding to 494,825 voting rights). 7. HBM Healthcare Investments AG, Bundesplatz 1, 6301 Zug, Switzerland, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 9.44% on October 27, 2014 (corresponding to 494,825 voting rights). 9.44% of the voting rights (corresponding to 494,825 voting rights) are to be attributed to HBM Healthcare Investments AG pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to HBM Healthcare Investments AG are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: HBM Healthcare Investments (Cayman) Ltd. 8. Edmond de Rothschild Investment Partners, 47 rue du Faubourg Saint Honoré, 75008 Paris, France, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 6, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 15.67% on October 27, 2014 (corresponding to 821,409 voting rights). 15.67% of the voting rights (corresponding to 821,409 voting rights) are to be attributed to Edmond de Rothschild Investment Partners pursuant to sec. 22 para. 2 sentence 1 no. 6 WpHG. 9. IBG Risikokapitalfonds I GmbH & Co. KG, KantstraÃe 5, 39104 Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 9.51% on October 27, 2014 (corresponding to 498,549 voting rights). 10. IBG Risikokapitalfonds II GmbH & Co. KG, KantstraÃe 5, 39104 Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 7.71% on October 27, 2014 (corresponding to 404,261 voting rights). 11. IBG Beteiligungsverwaltung Komplementär GmbH, KantstraÃe 5, 39104 Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 17.48% on October 27, 2014 (corresponding to 916,435 voting rights). 17.48% of the voting rights (corresponding to 916,435 voting rights) are to be attributed to IBG Beteiligungsverwaltung Komplementär GmbH pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to IBG Beteiligungsverwaltung Komplementär GmbH are held via the following companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: IBG Risikokapitalfonds I GmbH & Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG. 12. IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, KantstraÃe 5, 39104 Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 18.12% on October 27, 2014 (corresponding to 949,607 voting rights). 17.48% of the voting rights (corresponding to 916,435 voting rights) are to be attributed to IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH are held via the following companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: IBG Beteiligungsverwaltung Komplementär GmbH, IBG Risikokapitalfonds I GmbH & Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG. 13. Sachsen-Anhalt, Land - Ministerium der Finanzen des Landes Sachsen-Anhalt, Olvenstedter StraÃe 1-2, 39108 Magdeburg, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 18.12% on October 27, 2014 (corresponding to 949,607 voting rights). 18.12% of the voting rights (corresponding to 949,607 voting rights) are to be attributed to Sachsen-Anhalt, Land - Ministerium der Finanzen des Landes Sachsen-Anhalt, pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to Sachsen-Anhalt, Land - Ministerium der Finanzen des Landes Sachsen-Anhalt, are held via the following companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, IBG Beteiligungsverwaltung Komplementär GmbH, IBG Risikokapitalfonds I GmbH & Co. KG, IBG Risikokapitalfonds II GmbH & Co. KG, 14. Biogen Idec MA Inc., 14 Cambridge Center, Cambridge, MA 02142, USA, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 5, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 4.04% on October 27, 2014 (corresponding to 211,651 voting rights). 15. Biogen Idec Inc., 225 Binney Street, Cambridge, MA 02142, USA, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 30, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 4.04% on October 27, 2014 (corresponding to 211,651 voting rights). 4.04% of the voting rights (corresponding to 211,651 voting rights) are to be attributed to Biogen Idec Inc. pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to Biogen Idec Inc. are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: Biogen Idec MA Inc. 16. TVM V Life Science Ventures GmbH & Co. KG, OttostraÃe 4, 80797 Munich, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 9.53% on October 27, 2014 (corresponding to 499,368 voting rights). 17. TVM V Life Science Management GmbH & Co. KG, OttostraÃe 4, 80797 Munich, Germany, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 9.53% on October 27, 2014 (corresponding to 499,368 voting rights). 9.53% of the voting rights (corresponding to 499,368 voting rights) are to be attributed to TVM V Life Science Management GmbH & Co. KG pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to TVM V Life Science Management GmbH & Co. KG are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: TVM V Life Science Ventures GmbH & Co. KG. 18. Wellington Hedge Management, LLC, Corporate Service Company, 84 State Street, Boston, MA 02109, USA, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 6, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 3.05% on October 27, 2014 (corresponding to 160,049 voting rights). 3.05% of the voting rights (corresponding to 160,049 voting rights) are to be attributed to Wellington Hedge Management, LLC pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. 19. Wellington Management Company, LLP, 280 Congress Street, Boston, Massachusetts 02210, USA, informed our company pursuant to sec. 21 para. 1a WpHG (German Securities Trading Act) on November 6, 2014, that its voting rights proportion in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, amounted to 4.06% on October 27, 2014 (corresponding to 212,771 voting rights). 4.06% of the voting rights (corresponding to 212,771 voting rights) are to be attributed to Wellington Management Company, LLP, pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG, and also concurrently pursuant to sec. 22 para. 2 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to Wellington Management Company, LLP are held via the following company whose holdings of voting rights amount to 3% or more in Probiodrug AG: Wellington Hedge Management, LLC. Halle (Saale), in November 2014 The Management 07.11.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Probiodrug AG: Release according to Article 26,
Top 10 Most Recent News Articles
Vector's Peptide Pact Needs Proof Before Any Payday
A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...
Continue Reading
Zunyi’s History Tour Carries China’s Story Overseas
China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...
Continue Reading
Lithium's Next Leg Depends on Storage, Not EV Hype
Grid batteries are quietly becoming lithium’s second engine, and that matters more than another flashy electric-vehicle sales headline. The market is projected to rise from $40.87 billion in 2026 to $57.77 billion by 2031, a 7.2% compound annual growth rate. Respectable growth, certainly. But this is not a straight line, and anybody treating a five-year market forecast...
Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless
A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...
Continue Reading
Villa Group’s Punta Mita Bet Adds 305 Luxury Resort Keys
A 12.6-acre slice of Riviera Nayarit coastline is about to get a very expensive makeover, assuming The Villa Group can turn a handsome plan into a functioning resort without the usual development headaches. The company says it has acquired a beachfront parcel in Litibú and intends to build Villa La Valencia Punta Mita, a 305-accommodation luxury property aimed squarely...
Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone
A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...
Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany
A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...
Continue Reading
Tronox Pushes Back on Creditor Restructuring Chatter Firmly
A Creditor Rumor Is Not a Restructuring Plan Two creditor groups hiring law firms can make a stock chart look like it stepped on a rake, but it is not the same thing as a debt workout. That distinction is the whole point of Tronox Holdings' November 18 update. A November 17 Wall Street Journal report said two groups of creditors had retained firms described as...
Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital
Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....
Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft
Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...
Continue ReadingTop 5 Most Recently Viewed Articles
San Jose Workers Ready to Strike Amid Contract Woes
Strike Looms Over San Jose City Workers Can't say I blame these San Jose city workers. They're at their wits' end, caught in what's feeling like an endless round of negotiations that just aren't getting anywhere. July 29 saw hundreds of city employees packed into Strike School sessions, seriously gearing up for what's looking like a showdown with city officials. Ain't a...
Continue Reading
Foot Health Revolution: Custom Orthotic Insoles Lead Market Surge
Understanding the Custom Foot Orthotic Insoles Market Growth The Custom Foot Orthotic Insoles Market is experiencing remarkable growth driven by a series of key factors. The increasing awareness surrounding foot health, including the benefits of personalized support, plays a pivotal role in this expansion. As more individuals recognize the advantages provided by custom...
Continue Reading
Columbus McKinnon Announce Regular Dividend of $0.07
Columbus McKinnon Corporation Declares Quarterly Dividend Columbus McKinnon Corporation (NASDAQ: CMCO), an established leader in intelligent motion solutions for material handling, has made a significant announcement regarding its dividend. The Board of Directors has affirmed their commitment to shareholders by declaring a regular quarterly dividend of $0.07 per common...
Continue Reading
System Integration Market Set for 13.5% Growth by 2033
Understanding the Growth of the System Integration Market The global system integration market plays a vital role in the technology sector by enabling the smooth integration of various subsystems, software applications, and IT infrastructures into a unified operational framework. This market is essential for businesses looking to boost productivity, streamline processes,...
Continue Reading
Zoom Earnings Report: Analysts Revise Forecasts and Outlook
Anticipation Builds for Zoom's Earnings Announcement Zoom is on the brink of dropping its fourth-quarter earnings results; brace yourself for some market action come Wednesday, February 25. This isn't just any quarterly call; it could show whether Zoom still has the magic touch or if it's leaning hard on its video-chat crutch amid growing competition and changing...
Continue Reading